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Nephrolithiasis has many causes, and its prevalence is increasing worldwide. The 
interest in the human microbiome is growing because of the advance of new 
diagnostic techniques, and recent studies have suggested a link between the 
microbiome and nephrolithiasis. This paper reviewed the role of the microbiome 
in nephrolithiasis. The absence of Oxalobacter formigenes induces hyperoxaluria, 
which promotes calcium oxalate stone (CaOx) formation. Escherichia coli promote 
CaOx supersaturation through hypocitraturia caused by the bacterial production 
of citrate lyase. Infection stones are associated with urea-splitting organisms, 
particularly Proteus mirabilis, and the stones themselves contain many species of 
bacteria.
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Nephrolithiasis is one of the most frequently encountered 
urologic diseases, and its incidence and prevalence are 
increasing worldwide. The prevention of nephrolithiasis is 
essential, but its etiology is variable and complex, involving 
geographical, climatic, ethnic, dietary, and genetic factors [1].
Attention to the contributions of the gastrointestinal and 
urinary microbiome in nephrolithiasis has increased recently 
[2]. Lederberg and McCray [3] first defined the microbiome 
as the ecological community of commensal, symbiotic, and 
pathogenic microorganisms sharing the body space. 
Advances in molecular techniques have enabled a more 
comprehensive assessment of the microorganisms present 
in urine [4]. 16S ribosomal RNA (rRNA) gene sequencing 
can identify bacteria in healthy urine [5-8]. Expanded 
quantitative urine culture (EQUC) resolves the discrepancies 
between cultures and molecular assays. EQUC can also 
determine if the bacteria in urine are alive [5].
The Human Microbiome Project (HMP) was launched 
in 2008 to explore microbial communities and their 
connections with their human hosts [9]. On the other hand, 
the bladder was not included in the HMP initially. Samples 
were collected from the airways, skin, oral cavity, gut, and 
vagina [9]. Urine has historically been considered sterile in 
healthy individuals, but urine contains a variety of bacteria. 
These bacteria are not routinely cultivated but can be 
identified by 16S rRNA gene sequencing [10-12]. This paper 
reviewed the role of the microbiome in nephrolithiasis.
MAIN BODY
1. Pathophysiology of Urinary Stone Formation
The stone formation process involves precipitation, 
nucleation, crystal growth, and crystal aggregation [13]. 
Urinary supersaturation and crystallization cause intrarenal 
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crystal precipitation [14]. Calcium, oxalate, urate, and 
phosphate ions promote crystallization, and magnesium, 
citrate, pyrophosphate inhibit crystallization [15-17]. There 
are three hypotheses regarding the mechanisms of 
lithogenesis.
1) Randall’s plaque hypothesis
In 1937, Randall described [18] crystal growth from 
calcium phosphate plaques (Randall’s plaques) in the 
interstitium within the renal papilla at the base of the calyx 
in the kidney. Randall’s plaques are the first step toward 
calcium oxalate (CaOx) stone formation [14]. Damage to 
the renal tubular epithelium exposes the plaque to 
supersaturated urine, allowing CaOx stones to grow [19].
2) The free particle theory
In 1994, Kok and Khan [20] reported that large free 
crystalline particles could form in the long loop of Henle 
during normal transit time through the kidney. These 
particles obstruct the collecting ducts and form the nidus 
of a stone.
3) The fixed particle theory
Crystals attach to the renal tubular epithelium, leading 
to epithelial damage, nucleation, contact of nuclei with 
supersaturated urine, and crystal development. Brushite, 
cystine, and carbonate apatite crystals obstruct the inner 
medullary collecting ducts and ducts of Bellini, causing 
epithelial cell damage, inflammation, and focal interstitial 
fibrosis [21-23]. 
2. The Human Microbiome Project
The human body contains at least ten times more bacteria 
than human cells, and most bacteria are found in the human 
gut [24]. The HMP Consortium, which is an alliance of a 
broad collection of scientific experts funded by the US 
National Institutes of Health (NIH), was set up to study the 
relationship between the microbiome and human hosts [9]. 
The goals of the HMP are to form standardized resources 
for microbiome analysis, provide microbiome data to the 
scientific community for disease research, and promote the 
development of new technologies for microbiome analysis 
[25]. The project’s initial data contained 4,788 samples from 
242 screened and phenotyped adults (129 males, 113 
females). 16S rRNA gene sequencing and whole-genome 
shotgun sequencing were used for analysis [26]. Microbiome 
samples were collected from 15 distinct body sites in both 
men and women. Three additional sites in the vagina were 
included for females [26]. The specimens included the oral 
cavity and oropharynx, skin, and stool [26]. The HMP 
currently aims to sequence at least 3,000 reference microbial 
genomes relevant to the human body and make them 
available from the National Center for Biotechnology 
Information and the Data Analysis and Coordination Center 
(http://hmpdacc.org/HMRGD) [9]. It will also offer a 
database to support future research [25].
3. Gut Microbiome and Urolithiasis
1) Bacteria that degrade oxalate
Oxalobacter formigenes rely on oxalate in the intestines 
as a carbon source for energy and growth [27]. In the US, 
O. formigenes colonizes 38-62% of adults. In India and Korea, 
the colonization percentage in adults is approximately 60% 
and 77%, respectively [28,29]. Dawson et al. [30] isolated 
anaerobic bacteria from sheep rumen, later defined as O. 
formigenes that relied on oxalate for energy. Allison et al. 
[31] described the same bacteria from human feces. The 
clinical results indicated a direct connection between the 
organism’s absence, hyperoxaluria, and the formation of 
oxalate stones. Numerous oxalate-degrading bacteria exist, 
such as Lactobacillus, Bifidobacterium, Enterococcus, 
Clostridium, Eggerthella, Providencia, Streptococcus, and 
Leuconostoc genera [32]. Increased oxalate degradation by 
the gastrointestinal microbiome may decrease oxalate 
absorption and reduce urinary oxalate excretion [33].
Siener et al. [34] suggested that the absence of O. 
formigenes induces hyperoxaluria, which may cause the 
formation of CaOx stones. Of 37 idiopathic CaOx stone 
patients, only 11 (30%) tested positive for O. formigenes, 
while 26 (70%) were negative in the stool culture and stool 
polymerase chain reaction. Moreover, 60-80% of patients 
who formed multiple stones were negative for O. formigenes. 
On the other hand, there were no differences in 24-hour 
urine oxalate between O. formigenes-negative and O. 
formigenes-positive. This result contradicts the previously 
assumed mechanism through which the absence of O. 
formigenes, as described previously, causes hyperoxaluria. 
Ticinesi et al. [35] analyzed the microbiome composition 
through 16S rRNA microbial profiling and shotgun 
metagenomics analysis of fecal samples from 52 idiopathic 
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calcium stone formers and 48 controls. Three taxa (Dorea, 
Enterobacter, and Faecalibacterium) were underrepresented 
in stone formers (p＜0.05). Very few O. formigenes were 
detected in analyzed fecal samples (＜0.001% in all samples), 
and the average relative abundance of O. formigenes was 
similar between stone formers and controls. The relative 
abundances of five taxa (Defluviitaleaceae, Catabacter, 
Anaerofilum, Sutterella, and Peptococcus) were significantly 
associated with the 24-hour urinary oxalate excretion in 
both stone formers and controls. Defluviitaleaceae, 
Sutterella, and Peptococcus showed a positive association, 
while Catabacter and Anaerofilum showed a negative 
association. Bacteroides, Actinobacteria, Alistipesindistinctus, 
and Odoribactersplanchnicus were more abundant in 
nephrolithiasis patients than the healthy controls [36]. The 
fecal samples of stone formers had a significantly lower 
bacterial representation of genes related to oxalate 
degradation, and gene expression was inversely correlated 
with the 24-hour oxalate excretion (r=−0.87, p=0.002). 
Oxalate-degrading genes were expressed in several bacterial 
species, and gene expression was inversely correlated with 
oxaluria (r=−0.85, p=0.02). Faecalibacterium produces 
short-chain fatty acids that attenuate inflammation and 
oxidative stress associated with kidney stone formation [37].
Batagello et al. [38] performed a meta-analysis of the gut 
microbiome in nephrolithiasis. They concluded that O. 
formigenes was not a good predictor of the nephrolithiasis 
risk. Although studies consistently reported a higher level 
of colonized O. formigenes in healthy controls than urinary 
stone patients, six out of 14 studies reported no significant 
impact of O. formigenes on the urinary oxalate levels. O. 
formigenes colonization ranged from 11% to 100% in healthy 
controls and 0% to 100% in urinary stone patients. They 
concluded that targeting a broad diversity of bacteria is 
necessary for microbiome analysis rather than focusing on 
a few species. 
4. Urinary Microbiome and Stones
1) Escherichia coli
High-throughput sequencing has shown that nephrolithiasis 
involves the Enterobacteriaceae genus in the urinary 
microbiome, including E. coli species [39]. Barr-Beare et 
al. [40] reported associations between E. coli and renal CaOx 
deposits. Mice with uropathogenic E. coli inoculation had 
a 2.7 times higher rate of calcium deposition. Several theories 
can explain the association between urinary bacteria and 
nephrolithiasis. The bacteria may adhere to CaOx crystals 
and cause pyelonephritis, and the resulting biofilm may 
promote crystal agglomerations. In addition, CaOx 
supersaturation in hypocitraturia caused by the bacterial 
production of citrate lyase may encourage stone formation 
[40-42].
2) Urea-splitting organisms
Organisms, including Proteus, Staphylococcus, Klebsiella, 
and Pseudomonas, decompose urea in urine. The decom-
position generates ammonia, bicarbonate, and carbonate, 
alkalizing the urine. These decomposition products form 
crystals with calcium, magnesium, and phosphoric acid in 
the urine that form infection stones (struvite or carbonate 
apatite) [43,44]. The bacterium most commonly associated 
with infection stones is Proteus mirabilis [45]. 
5. Microbiome in Stones 
Bacteria can be isolated from approximately 15-70% of 
stones [46-48]. CaOx stones contained positive cultures in 
13% to 44% of samples. E. coli (15-35%) was the most common 
bacteria identified from stone cultures, followed by 
Pseudomonas spp. and Proteus (urease-producing bacteria), 
which are typically associated with the formation of struvite 
stones [46,47].
Dornbier et al. [49] analyzed the microbiome of 
calcium-based urinary stones. They identified the urine and 
stone microbiota of nephrolithiasis patients using 16S rRNA 
gene sequencing and EQUC. Bacteria were identified in 29/52 
(55.8%) of stones. Enterobacteriaceae (including the genera 
Escherichia and Klebsiella), Staphylococcus, Veillonella, 
Streptococcus, Corynebacterium, Haemophilus, Proteus, 
Lactobacillus, and Bifidobacterium were dominant the 
bacterial taxa. Twelve stones contained dominant bacterial 
taxa, and 5/12 (41.7%) of these were CaOx stones. In contrast, 
36/40 (90%) of stones without dominant taxa were CaOx. 
EQUC and 16S-rRNA gene sequencing identified multiple 
enriched bacterial species, including Staphylococcus 
epidermidis, Enterobacter cloacae, Escherichia coli (a 
member of the family Enterobacteriaceae), and Lactobacillus 
gasseri. Dornbier et al. [49] developed a methodology to 
detect bacteria in stones and estimate whether they are more 
abundant in the urine than other species. Table 1 lists the 
microbiome associated with nephrolithiasis.
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Table 1. Microbiome associated with nephrolithiasis
Gut microbiome Urinary microbiome Stone microbiome
Known oxalate-degrading bacteria Escherichia coli Staphylococcus, Veillonella, Streptococcus
    Oxalobacter formigenes Urea-splitting organisms (Proteus, 
Staphylococcus, Klebsiella, Pseudomonas)
Corynebacterium, Haemophilus, Proteus
    Lactobacillus Lactobacillus, Bifidobacterium, Enterobacteriaceae
    Bifidobacterium
    Enterococcus
    Clostridium
    Eggerthella
    Providencia
    Streptococcus
    Leuconostoc
Related to 24-hour urine oxalate excretion
    Defluviitaleaceae
    Catabacter
    Anaerofilum
    Sutterella
    Peptococcus
Lower in stone formers
    Dorea
    Faecalibacterium
    Enterobacter
Higher in stone formers
    Bacteroidetes
    Acinobacteria
    Alistipesindistinctus
    Odoribactersplanchnicus
6. Standardization of Microbiome Studies for 
Nephrolithiasis
Kachroo et al. [2] developed MICROCOSM (MICRObiome 
contributions on the Complexity Of the Stone Matrix), which 
focused on the relationship between the microbiome and 
urolithiasis. The goal of MICROCOSM was to standardize 
the protocol for microbiome research within the field of 
urolithiasis to minimize the technical biases and barriers 
related to microbiome studies. Similar results were found 
in studies comparing the microbiomes of patients with stones 
with the microbiomes of healthy controls. On the other hand, 
despite some apparent differences between patients with 
stones and healthy controls [38], there were inconsistencies 
in the compositions of the microbiomes correlating with 
the disease [2]. MICROCOSM was developed to minimize 
the discrepancies in microbiome research resulting from 
experimental factors, such as sample collection, storage, 
DNA extraction, sequencing, or data analysis.
7. Probiotics for Prevention of Nephrolithiasis
The endogenous digestive microbiome, which utilizes 
oxalate, potentially prevents oxalate absorption [50]. On the 
other hand, studies with probiotics, including Oxalobacter, 
Lactobacillus, and Bifidobacterium, showed disappointing 
results [33].
1) Probiotics containing Lactobacillus
A pilot study with Oxadrop® reduced urine oxalate 
excretion by 40% in mildly hyperoxaluric CaOx stone 
patients [51]. In subsequent research, 10 patients with enteric 
hyperoxaluria were treated daily with Oxadrop® and 
received 4 g, 8 g, and 12 g each month for three months 
[52]. This study showed a dose-dependent effect until the 
second month. The patients administered 4 g and 8 g 
exhibited a 19% and 24% decrease in urine oxalate excretion, 
respectively. On the other hand, during the third month, 
at 12 g per day, urine oxalate excretion increased in four 
out of 10 patients, which was close to the baseline established 
without treatment. No effects on urinary oxalate excretion 
were observed in a randomized, placebo-controlled study 
[53].
2) Probiotics containing Oxalobacter
Research in a mouse model of type 1 primary 
hyperoxaluria demonstrated that oral administration of O. 
formigenes might decrease urinary oxalate excretion [54]. 
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In a pilot study of nine patients (five with normal renal 
function, four with primary hyperoxaluria), urine oxalate 
excretion was reduced by 50% for four weeks by admin-
istering an oral preparation of O. formigenes in four with 
primary hyperoxaluria patients [55]. In this study, three out 
of five patients with normal renal function exhibited a 
22-48% decrease in urinary oxalate excretion while taking 
the first oral formulation of O. formigenes. Moreover, O. 
formigenes did not establish persistent gut colonies, so the 
beneficial effects depended on the continual administration 
of probiotics. Despite the hopeful preliminary data, there 
was no follow-up controlled trial using O. formigenes in 
patients with enteric or idiopathic hyperoxaluria. Therefore, 
the effect of probiotics containing O. formigenes on urinary 
oxalate excretion requires more investigation [33]. 
CONCLUSIONS 
The absence of O. formigenes may cause enteric 
hyperoxaluria, but the colonization rate of O. formigenes 
varies in healthy people and urinary stone patients. 
Furthermore, the presence of Faecalibacterium, Enterobacter, 
and Dorea in stone formers may reduce the likelihood that 
CaOx stones will form. Faecalibacterium may attenuate the 
inflammation and oxidative stress associated with stone 
formation. In mice, urine E. coli could promote CaOx stone 
formation. On the other hand, CaOx stones do not contain 
large amounts of microorganisms, and no organisms were 
present in uric acid and cystine stones. A standardized study 
on the correlation between the stool and urine microbiome 
and stone formation is currently ongoing, and the effects 
of probiotics on oxalate degradation require more research. 
The microbiome likely plays a role in forming nephrolithiasis, 
but more research will be needed.
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